We herein investigated the effects of ramelteon, an antioxidant and sleep inducer, on nocturia unresponsive to α1-blocker monotherapy in males with lower urinary tract symptoms (LUTS) as a pilot ...
Ramelteon acts as an MT 1 and MT 2 melatonin receptor agonist, showing higher affinities for these receptors than does the natural ligand Ramelteon induces sleep initiation and maintenance, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback